Package 62135-937-54

{"route": ["ORAL"], "spl_id": "f1d8692b-deb3-d55f-e053-2a95a90ae615", "openfda": {"nui": ["N0000180292", "N0000175365"], "upc": ["0362135008567", "0362135937546"], "unii": ["4B33BGI082"], "rxcui": ["848943", "1801279"], "spl_set_id": ["80db0042-0c05-4509-8a6b-fa9f4783629a"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "239.4 g in 1 CAN (62135-937-54)", "package_ndc": "62135-937-54", "marketing_start_date": "20230103"}], "brand_name": "Cholestyramine for Oral Suspension", "product_id": "62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615", "dosage_form": "POWDER", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "62135-937", "generic_name": "Cholestyramine for Oral Suspension", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine for Oral Suspension", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/5.7g"}], "application_number": "ANDA074562", "marketing_category": "ANDA", "marketing_start_date": "19960815", "listing_expiration_date": "20261231"}